Drugs / ACTH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01950234 | Apr 2014 → Dec 2022 | primary progressive multiple sclerosis, progressive relapsing multiple sclerosis, secondary progressive multiple sclerosis | University of Minnesota | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01950234 ↗ |
| Route | Subcutaneous | “ACTH administered subcutaneously” NCT01950234 ↗ |